Evidence map›Paper›PMID 36399478›Full record

ArticleNucleic acids research2023

MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database.

Xinhao Shao, Clarissa D Gomez, Nandini Kapoor, James M Considine, Christopher Grams, Yu Tom Gao, Alexandra Naba

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 1 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 1 synthesis or guideline pooled it, 192 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. ADAMTS14 is a novel modulator of fibroblast mechanoactivation in pulmonary fibrosis.American journal of respiratory and critical care medicine · 2026
    Article
  4. Article
  5. Understanding and targeting the tumour matrisome.Nature reviews. Clinical oncology · 2026
    Review
  6. Article
  7. Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  8. STK40 inhibits profibrotic Arg1Acta pharmacologica Sinica · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Ex vivo assay for organ-specific cancer cell invasion.Journal of biological engineering · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Glutamine-dependent changes in fibroblast-derived extracellular matrix dictate cancer cell behavior.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xinhao ShaoDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
Clarissa D GomezDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, USA.
Nandini KapoorDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, USA.
James M ConsidineDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, USA.
Christopher GramsDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
Yu Tom GaoDepartment of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
Alexandra NabaDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0002-4796-5614
University of Illinois Chicago · US

Funding

Highly sensitive proteomics method to probe cell heterogeneity at single cell resolutionR35GM133416 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Yu Gao · 2019 to 2026
$2.4M
Thinking outside the cell: Leveraging HuBMAP data to build the human ECM atlasU01HG012680 · NHGRI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAO, YU, NABA, ALEXANDRA · 2022 to 2025
$2.0M
Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrixR21CA261642 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAO, YU, NABA, ALEXANDRA · 2022 to 2024
$553k
NCI NIH HHS R21 CA261642NHGRI NIH HHS U01 HG012680NIGMS NIH HHS R35 GM133416
6 · The paper itself

Abstract

The extracellular matrix (ECM) is a complex assembly of proteins that constitutes the scaffold organizing cells, tissues, and organs. Over the past decade, mass-spectrometry-based proteomics has become the method of choice to profile the composition of the ECM, or the matrisome, of tissues. To assist non-specialists with the reuse of ECM proteomic datasets, we released MatrisomeDB (https://matrisomedb.org) in 2020. Here, we report the expansion of the database to include 25 new curated studies on the ECM of 24 new tissues in addition to datasets on tissues previously included, more than doubling the size of the original database and achieving near-complete coverage of the in-silico predicted matrisome. We further enhanced data visualization by maps of peptides and post-translational-modifications detected onto domain-based representations and 3D structures of ECM proteins. We also referenced external resources to facilitate the design of targeted mass spectrometry assays. Last, we implemented an abstract-mining tool that generates an enrichment word cloud from abstracts of studies in which a queried protein is found with higher confidence and higher abundance relative to other studies in MatrisomeDB.

Indexed as

Extracellular Matrix ProteinsProteomicsDatabases, ProteinExtracellular MatrixMass SpectrometryExtracellular Matrix Proteins

Identifiers

PMID36399478
PMCPMC9825471
OpenAlexW4309306080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.